E-DRUG: Counterfeiter sentenced to jail term in UK
-------------------------------------------
Dear E-Druggers
A story from the UK of a drug counterfeiter / collaborator being
sentenced to a prison term for his activities (from PharmaTimes as fair
use). Hopefully we will one day get to the point where this is
happening to those operating in lower-income countries.
Regards
Douglas Ball
ResultsinHealth, Netherlands
douglasball [AT] yahoo.co.uk
------------------------
Man jailed for worst ever breach of medicines supply chain
http://www.pharmatimes.com/Article/11-04-12/Man_jailed_for_worst_ever_breach_of_medicines_supply_chain.aspx
A British man has been sentenced to eight years in prison for his role
in what law enforcers describe as the "most serious known breach" of the
regulated UK medicines supply chain.
Following a four-month trial in Croydon Crown Court, 64-year old Peter
Gillespie was found guilty for working with an international network of
criminals to inject fake drugs into the UK's legitimate supply chain
during a five-month period in 2007. The case, known as Operation
Singapore, centred on the importation of more than two million doses of
counterfeit life-saving medicines into the country. More than half of
these were captured by the Medicines and Healthcare products Regulatory
Agency, but a huge amount - almost 900,000 doses - initially reached
pharmacies and patients. Despite an immediate recall of Eli Lilly's
antipsychotic Zyprexa (olanzapine), Bristol-Myers Squibb's bloodthinner
Plavix (clopidogrel) and AstraZeneca's prostate cancer drug Casodex
(bicalutamide), 700,000 doses were left unaccounted for, putting the
health of many Britons in jeopardy.
Mick Deats, the MHRA's head of enforcement, also revealed that plans to
bring in three other counterfeit drugs - Pfizer/Eisai's Alzheimer's drug
Aricept (donepezil), UCB's antiepileptic Keppra (levetiracetam) and
Johnson & Johnson's antipsychotic Risperdal (risperidone) - had been foiled.
*Plans foiled*
"They didn't get to bring them in but they were definitely well on the
way to being prepared to receive them," he told the media, according to
Reuters. "This is serious criminal activity and puts people's lives at
risk," Deats said, and stressed that the Agency would not hesitate "to
take all appropriate action to eliminate the risks posed by counterfeit
medicines and take action against those engaged in their supply".
However, he also noted current evidence suggests that medicines supplied
through the UK legitimate supply chain are genuine and safe to take.
Since 2004 there have been just 15 known instances of counterfeit
medicines in the UK regulated supply chain, and given that 850 million
prescriptions are dispensed every year in the UK, the likelihood of
receiving a counterfeit medicine remains extremely rare, the MHRA said.